Irreversible Electroporation for Enlargement
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is a prospective, multi-center, single-arm study of pediatric subjects (age 3-12) with Sleep-Disordered Breathing ("SDB") due to adeno-tonsillar hypertrophy which are treated with the ENTire IRE System.
Subjects will be followed for six (6) months post-treatment. The objective of the study is to provide an ongoing safety and effectiveness assessment of the ENTire IRE System in treating pediatric adeno-tonsillar hypertrophy.
Are You a Good Fit for This Trial?
This trial is for children ages 3 to 12 who have trouble breathing during sleep because their tonsils and adenoids are enlarged. They must be able to undergo the procedure and follow-up visits.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- ENTire IRE System
Trial Overview
The study tests a device called the ENTire IRE System, which uses irreversible electroporation (a type of energy treatment) on enlarged tonsils and adenoids in kids with sleep-disordered breathing. All participants receive this treatment and are monitored for six months.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
ENTire Medical Ltd.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.